ArticleTranslational oncology2025

Novel p53 reactivators that are synergistic with olaparib for the treatment of gynecologic cancers with mutant p53.

Lane E Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.